RVXCF Message Board Post 9191570 | Resverlogix Corp
home / stock / rvxcf / rvxcf message board
Claytonfrankh
(investorshub)
Posted on: Feb/03/2020 13:44:11
Source: investorshub
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=153621560
Yes! Much quicker than expected!
News, Short Squeeze, Breakout and More Instantly...
-
Calgary, Alberta--(Newsfile Corp. - May 13, 2024) - Resverlogix Corp. (TSX: RVX) ("Resverlogix" or the "Company") announced today a two-year extension of the Company's US$6.0 million secured convertible debenture with Shenzhen Hepalink Pharmaceutical Group Co., Ltd. ("Hepalink") (and payment of a...
-
2024-03-27 17:08:02 ET Developing safe, epigenetic therapeutics for people suffering from chronic illnesses Resverlogix is a late-stage clinical biotechnology company dedicated to improving the lives of patients with chronic illnesses and providing value-based health solutions...
-
2024-03-27 17:08:02 ET The future of drug development Resverlogix is committed to developing epigenetic therapies for the benefit of patients with chronic disease. Their current clinical program focuses on advancing their lead compound ( apabetalone) and evaluating its th...